top of page

Scientific studies on mRNA

A Case Report of Acute Lymphoblastic Leukaemia (ALL) Lymphoblastic Lymphoma (LBL) Following the Second Dose of Comirnaty

Cancer

A case of metastatic BRAFV600-mutated melanoma with heart failure treated with immune checkpoint inhibitors and BRAF MEK inhibitors

Cancer

A case of fulminant type 1 diabetes mellitus after COVID-19 vaccination during treatment of advanced gastric cancer, pitfall in managing immune-related adverse events

Cancer

Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine

Bullous Drug Eruption

Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine An analysis of European data

Bleeding Episodes

SHEDDING OF COVID mRNA VACCINES

Vaccine Shedding

Inadvertent Exposure to Pharmacologically Designed Lipid Nanoparticles Via Bodily Fluids, Biologic Plausibility and Potential Consequences

Vaccine Shedding

Current state of knowledge on the excretion of mRNA and spike producedbyanti-COVID-19 mRNA vaccines, possibility of contamination of the entourageofthose vaccinated by these products.pdf

Vaccine Shedding

Vasculitis and bursitis

Vaskulitis

Small vessel vasculitis related to varicella-zoster virus after Pfizer-BioNTech COVID-19 vaccine

Vaskulitis

Reactivation of IgA vasculitis following COVID-19 vaccination

Vaskulitis

Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis after COVID-19 Vaccination

Vaskulitis

Post‐COVID‐19 vaccination IgA vasculitis in an adult

Vaskulitis

New‐onset leukocytoclastic vasculitis after COVID‐19 vaccine

Vaskulitis

Nephrotic syndrome and vasculitis following SARS-CoV-2 vaccine true association or circumstantia

Vaskulitis

Leukocytoclastic vasculitis flare following the COVID-19 vaccine

Vaskulitis

Leukocytoclastic Vasculitis After Vaccination With a SARS‐CoV‐2 Vaccine

Vaskulitis

Intracerebral hemorrhage due to vasculitis following COVID-19 vaccination

Vaskulitis

First description of immune complex vasculitis after COVID-19 vaccination with BNT162b2

Vaskulitis

Cutaneous vasculitis following COVID-19 vaccination.

Vaskulitis
bottom of page